AI Article Synopsis

  • Direct current cardioversion (DCCV) is a procedure used to treat atrial fibrillation, and a study compared follow-up methods between remote photoplethysmography (PPG) and traditional 12-lead electrocardiograms (ECG).
  • The analysis involved 416 patients, showing high compliance rates for both methods, but PPG was more cost-effective, saving money and travel time for patients while also reducing carbon emissions.
  • Ultimately, the study concluded that remote PPG monitoring is a practical alternative for post-DCCV arrhythmia follow-up, with no safety concerns reported.

Article Abstract

Aims: Direct current cardioversion (DCCV) is a commonly utilized rhythm control technique for atrial fibrillation. Follow-up typically comprises a hospital visit for 12-lead electrocardiogram (ECG) two weeks post-DCCV. We report the feasibility, costs, and environmental benefit of remote photoplethysmography (PPG) monitoring as an alternative.

Methods And Results: We retrospectively analysed DCCV cases at our centre from May 2020 to October 2022. Patients were stratified into those with remote PPG follow-up and those with traditional 12-lead ECG follow-up. Monitoring type was decided by the specialist nurse performing the DCCV at the time of the procedure after discussing with the patient and offering them both options if appropriate. Outcomes included the proportion of patients who underwent PPG monitoring, patient compliance and experience, and cost, travel, and environmental impact. Four hundred sixteen patients underwent 461 acutely successful DCCV procedures. Two hundred forty-six underwent PPG follow-up whilst 214 underwent ECG follow-up. Patient compliance was high (PPG 89.4% vs. ECG 89.8%; > 0.999) and the majority of PPG users (90%) found the app easy to use. Sinus rhythm was maintained in 71.1% (PPG) and 64.7% (ECG) of patients ( = 0.161). Twenty-nine (11.8%) PPG patients subsequently required an ECG either due to non-compliance, technical failure, or inconclusive PPG readings. Despite this, mean healthcare costs (£47.91 vs. £135 per patient; < 0.001) and median cost to the patient (£0 vs. £5.97; < 0.001) were lower with PPG. Median travel time per patient (0 vs. 44 min; < 0.001) and CO emissions (0 vs. 3.59 kg; < 0.001) were also lower with PPG. No safety issues were identified.

Conclusion: Remote PPG monitoring is a viable method of assessing for arrhythmia recurrence post-DCCV. This approach may save patients significant travel time, reduce environmental CO emission, and be cost saving in a publicly-funded healthcare system.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11284012PMC
http://dx.doi.org/10.1093/ehjdh/ztae028DOI Listing

Publication Analysis

Top Keywords

ppg
12
ppg monitoring
12
atrial fibrillation
8
remote ppg
8
ppg follow-up
8
ecg follow-up
8
patients underwent
8
underwent ppg
8
patient compliance
8
0001 lower
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!